摘要
目的探讨长链非编码RNA HOXA-AS2(lncRNA HOXA-AS2)对视网膜母细胞瘤细胞增殖和上皮间质转化(EMT)的影响。方法选取对数期NCI-H187人视网膜母细胞瘤细胞,采用随机数表法分为lncRNA HOXA-AS2组、对照组和空白组,分别转染pc DNA3.0-lncRNA HOXA-AS2、pc DNA3.0-NC和磷酸盐缓冲液。采用qRT-PCR检测lncRNA HOXA-AS2表达,CCK-8法检测细胞增殖指数,Annexin V FITC/PI法检测细胞凋亡指数,Transwell小室检测细胞侵袭指数,Western Blot检测Vimentin表达。结果转染后24h和48h,lncRNA HOXA-AS2组细胞的lncRNA HOXA-AS2表达水平、细胞增殖指数、细胞凋亡指数、细胞侵袭指数和Vimentin蛋白相对表达水平均高于空白组和对照组,差异均有统计学意义(均P<0.05)。结论过表达lncRNA HOXA-AS2能促进视网膜母细胞瘤细胞增殖、侵袭与凋亡,利于肿瘤细胞发生EMT,抑制肿瘤细胞凋亡。
Objective To investigate the effects of LncRNA HOXA-AS2 on the proliferation and epithelial-mesenchymal transition(EMT)of retinoblastoma cells.Methods NCI-H187 human retinoblastoma cells at a logarithmic growth were selected and randomly divided into three groups,say,a LncRNA HOXA-AS2 group,a control group and a blank group.These three groups were transfected with pc DNA3.0-lncRNA HOXA-AS2,pc DNA3.0-NC and phosphate buffer,respectively.Quantitative reverse transcription polymerase chain reaction(qRT-PCR)was used to detect the expression of LncRNA HOXA-AS2.Cell counting kit-8(CCK-8)was used to detect cell proliferation index.Annexin V-FITC/PI was used to detect cell apoptosis index.Transwell chambers were used to detect cell invasion index.Western blot was used to detect Vimentin expression.Results At 24 h and 48 h after the transfection,the expression level of LncRNA HOXA-AS2,cell proliferation index,cell invasion index,and relative expression level of Vimentin protein were higher in the LncRNA HOXA-AS2 group than those in the blank group and the control group(all P<0.05),and the apoptosis indexes were lower than in the blank group and the control group(all P<0.05).Conclusion Over-expression of LncRNA HOXA-AS2 can promote the proliferation and invasion of retinoblastoma cells,which is beneficial to the occurrence of EMT of tumor cells and inhibits tumor apoptosis.
作者
曲来强
彭静
喻磊
严宏
陈红
QU Lai-qiang;PENG Jing;YU Lei;YAN Hong;CHEN Hong(Department of Ophthalmology,Xi’an People’s Hospital/Xi’an Fourth Hospital,Xi’an 710004,China)
出处
《中国肿瘤临床与康复》
2021年第11期1308-1311,共4页
Chinese Journal of Clinical Oncology and Rehabilitation